NCT03967496

Brief Summary

Delirium is considered to be acute failure of central nervous system. It is acute confusional state characterized by decline from baseline mental level, attention deficit and disorganized thinking. Postoperative delirium is known to prolong length of stay in hospital, cause functional decline and dementia, increase all-cause mortality and increase the medical cost. It is also associated with other outcomes like cardiac arrest, ventricular tachycardia or fibrillation, myocardial infarction, pulmonary edema, pulmonary embolism, bacterial pneumonia, respiratory failure requiring intubation, renal failure requiring dialysis and stroke. There are well known predisposing and precipitating factors related to its etiology. However, the effect of type of anesthesia is not very clear. There have been no major clinical trials in this part of the world to delineate the incidence of immediate postoperative delirium (IPD). The investigators have undertaken this prospective observational study to determine the incidence of IPD and its etiological factors in adult patients during their stay in the Post-Anesthesia Care Unit (PACU) following surgery under different types of anesthesia (general anesthesia, regional anesthesia and monitored anesthesia care). The study was done over a period of about three months. Assessment for delirium was done using Confusion Assessment Method-Intensive Care Unit (CAM-ICU score, English/Arabic version). Sedation and Agitation were assessed using Richmond Agitation Sedation Score (RASS). Pain was assessed using Numeric Pain Score (NPS). Assessment was done within 24 hours prior to surgery and was repeated at three different intervals in PACU. Details of perioperative management were recorded and analyzed. The incidence of IPD and its etiologic factors were identified thereby leading to corrective action.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
402

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
Last Updated

May 30, 2019

Status Verified

May 1, 2019

Enrollment Period

3 months

First QC Date

May 19, 2019

Last Update Submit

May 26, 2019

Conditions

Keywords

deliriumpostoperative complicationsanesthesia recovery period

Outcome Measures

Primary Outcomes (3)

  • Onset of Immediate postoperative delirium (IPD) in adult patients

    Incidence of Immediate postoperative Delirium during Post-Anesthesia-Care-Unit (PACU) stay (at either 15 minutes or 30 minutes after end of anesthesia) as well as at the time of discharge from PACU

    During PACU stay up to 2 hours.

  • Implication of Type of Anesthesia on incidence of Immediate Postoperative Delirium

    Includes General Anesthesia (Inhalational as well as Total intravenous anesthesia), Regional Anesthesia and Monitored anesthesia care

    Intraoperative period

  • Effect of Perioperative risk factors on incidence of Immediate Postoperative Delirium

    Perioperative risk factors include: Electrolyte imbalance, anemia, co-morbidities like diabetes, hypertension, ischemic heart disease, chronic kidney diseases etc, preoperative medications like antihypertensives, oral hypoglycemics, insulin, antiplatelets, etc. All details of perioperative management were recorded.

    Perioperative period prior to delirium assessment.

Secondary Outcomes (4)

  • Postoperative Length of stay

    Postoperative period up to 8 weeks

  • Postoperative Complications

    Postoperative period up to 8 weeks

  • Mortality rate

    Postoperative episode up to 8 weeks

  • Percentage of cases requiring Postoperative Delirium treatment

    Postoperative period up to 8 weeks

Study Arms (3)

No Delirium

No Delirium: CAM-ICU score of less than 3 throughout Post-Anesthesia Care Unit stay

Procedure: Types of AnesthesiaProcedure: Access of SurgeryOther: ComorbiditiesDrug: Preoperative MedicationDiagnostic Test: Routine blood test

Initial Delirium

Initial Delirium: CAM-ICU score of 3 or more at 15 minutes following end of anesthesia and/or at 30 minutes following end of anesthesia

Procedure: Types of AnesthesiaProcedure: Access of SurgeryOther: ComorbiditiesDrug: Preoperative MedicationDiagnostic Test: Routine blood test

Delirium

Delirium: CAM-ICU score of 3 or more immediately prior to discharge from Post-Anesthesia Care Unit

Procedure: Types of AnesthesiaProcedure: Access of SurgeryOther: ComorbiditiesDrug: Preoperative MedicationDiagnostic Test: Routine blood test

Interventions

General Anesthesia includes: Inhalational anesthesia and total intravenous anesthesia. Regional blocks includes: Spinal Anesthesia, Epidural Anesthesia, Plexus Block, Peripheral Nerve Block,... etc Monitored Anesthesia Care: No anesthetic administered but care given for hemodynamic and blood sugar control intraoperatively.

Also known as: Regional Anesthesia, Monitored Anesthesia Care, General Anesthesia
DeliriumInitial DeliriumNo Delirium

Type of surgical access

Also known as: Endoscopy, Laparoscopy, Open surgery
DeliriumInitial DeliriumNo Delirium

A patient may have more than one comorbidity

Also known as: Diabetes, Hypertension, Acute Kidney injury, Chronic Kidney Dysfunction, Ischemic Heart Disease, Bronchial Asthma, Dyslipidemia, Sickle Cell Disease, No Comorbidity
DeliriumInitial DeliriumNo Delirium

Preoperative medications

Also known as: Metformin, Lisinopril, Amlodipine, Insulin, Atorvastatin, Hydralazine, Bisoprolol
DeliriumInitial DeliriumNo Delirium
Routine blood testDIAGNOSTIC_TEST

Preoperative and Intraoperative Investigations

Also known as: Serum hemoglobin, White cell count, Serum sodium, Serum potassium, Serum urea, Serum creatinine, Serum bicarbonate, Serum albumin, Random blood sugar
DeliriumInitial DeliriumNo Delirium

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All adults undergoing surgery with any type of anesthesia and any type of surgery under ASA grades 1-3, having no prior neurological abnormalities.

You may qualify if:

  • Adult patients (more than 18 years old) scheduled for Elective and Emergency surgery under anaesthesia.
  • Adult patients with ASA- 1 2 or 3 status (American Society of Anaesthesiologists Risk Stratification),
  • Patients getting anesthesia: general, regional and monitored anesthesia care.
  • Patients undergoing open/laparoscopic/endoscopic surgery.

You may not qualify if:

  • Refusal to consent
  • Patients with ASA- 4 and above risk stratification. Critically ill and unstable patients, shifted from ICU setting and for Emergency surgery.
  • Patients with neurological conditions like dementia, psychosis, depression, stroke, head injury and any other pre-existing neurological disease which may interfere with the assessment of delirium.
  • Extubation in deep plane of anesthesia where patient is not responsive to verbal commands.
  • Deaf and dumb patients
  • Inability to comprehend patient language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sultan Qaboos University Hospital,

Muscat, 123, Oman

Location

Related Publications (4)

  • Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941.

    PMID: 2240918BACKGROUND
  • Neufeld KJ, Leoutsakos JM, Sieber FE, Wanamaker BL, Gibson Chambers JJ, Rao V, Schretlen DJ, Needham DM. Outcomes of early delirium diagnosis after general anesthesia in the elderly. Anesth Analg. 2013 Aug;117(2):471-8. doi: 10.1213/ANE.0b013e3182973650. Epub 2013 Jun 11.

    PMID: 23757476BACKGROUND
  • Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, Haslauer CM, Donaldson MC, Whittemore AD, Sugarbaker DJ, Poss R, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA. 1994 Jan 12;271(2):134-9.

    PMID: 8264068BACKGROUND
  • Whitlock EL, Vannucci A, Avidan MS. Postoperative delirium. Minerva Anestesiol. 2011 Apr;77(4):448-56.

    PMID: 21483389BACKGROUND

MeSH Terms

Conditions

DeliriumPostoperative Complications

Interventions

Anesthesia, ConductionAnesthesia, GeneralEndoscopyLaparoscopyConversion to Open SurgeryComorbidityHemoglobin, SickleMetforminLisinoprilAmlodipineInsulinAtorvastatinHydralazineBisoprololLeukocyte Count

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersPathologic Processes

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeEpidemiologic FactorsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthHemoglobins, AbnormalHemoglobinsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsGlobinsHemeproteinsBiguanidesGuanidinesAmidinesOrganic ChemicalsDipeptidesOligopeptidesPeptidesDihydropyridinesPyridinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPyrrolesAzolesHeptanoic AcidsFatty AcidsLipidsPhthalazinesPyridazinesPhenoxypropanolaminesPropanolaminesAmino AlcoholsAlcoholsPropanolsAminesBlood Cell CountCell CountCytological TechniquesClinical Laboratory TechniquesHematologic TestsInvestigative TechniquesCell Physiological PhenomenaBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • ALI AL ABADI, MBCHB FRCA

    SULTAN QABOOS UNIVERSITY HOSPITAL

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
8 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2019

First Posted

May 30, 2019

Study Start

January 1, 2019

Primary Completion

March 31, 2019

Study Completion

March 31, 2019

Last Updated

May 30, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

As per the Institutional norms we are not supposed to share the data with regards to the study with others.

Locations